Consequence of the introduction of routine FCH PET/CT imaging for patients with prostate cancer: a dual centre survey

BACKGROUND: Fluorocholine(18F) (FCH) was introduced at the beginning of April 2010 in France, Slovenia and three other EU member states for the localisation of bone metastases of prostate cancer with PET. The aim of the study was to compare the evolution of diagnostic imaging in patients with prosta...

Descripción completa

Detalles Bibliográficos
Autores principales: Hodolic, Marina, Michaud, Laure, Huchet, Virginie, Balogova, Sona, Nataf, Valérie, Kerrou, Khaldoun, Vereb, Marika, Fettich, Jure, Talbot, Jean-Noël
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Association of Radiology and Oncology 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3908843/
https://www.ncbi.nlm.nih.gov/pubmed/24587775
http://dx.doi.org/10.2478/raon-2013-0049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3908843/
https://www.ncbi.nlm.nih.gov/pubmed/24587775
http://dx.doi.org/10.2478/raon-2013-0049

Ejemplares similares